ESOC 2024 | Inflammation as a stroke risk factor

Mira Katan, MD, MSc, FESO, University Hospital and University of Basel, Basel, Switzerland, discusses the significant role of inflammation as a stroke risk factor, playing a role in atherosclerosis, small vessel disease, and atrial fibrillation. She emphasizes the need for further research to understand inflammation’s impact and the importance of identifying high-risk patients for potential treatment with anti-inflammatory agents. This interview took place at the 10th European Stroke Organisation Conference (ESOC) 2024 in Basel, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.